Commenti a: Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances

Commenti a: Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances https://www.newpharmaitaly.it/final-phase-ii-results-for-ucbs-rozanolixizumab-in-primary-immune-thrombocytopenia-itp-published-in-blood-advances/ Il portale delle news in ambito farmaceutico Wed, 09 Sep 2020 03:00:48 +0000 hourly 1 https://wordpress.org/?v=7.0